| Devatis AG - Teriflunomid Devatis 14 mg QOD, Filmtabletten | | 69756 | | 02 | | Teriflunomid Devatis 14 mg QOD | | Filmtabletten | | L04AK02 | | Teriflunomide | | 25.02.2025 | | |
| | Composition | | teriflunomidum 14 mg, lactosum monohydricum 74.5 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum A, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, triacetinum, E 132, pro compresso obducto corresp. natrium max. 0.315 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Teriflunomidum | 14 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Teriflunomidum | 14 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 74.5 mg | | | Magnesii Stearas | | | | Maydis Amylum | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 28 | 365.21 | 414.80 | B | LS | Non |
|
|
